We provide an overview of 13 C magnetic resonance spectroscopy methods and their applications as an established metabolic tool with an emphasis on the use of high-resolution 13 C magnetic resonance spectroscopy and 13 C isotopomer analysis. Topics addressed include general properties of the 13 C magnetic resonance spectroscopy spectrum; different 13 C magnetic resonance spectroscopy acquisition protocols; determination of fractional 13 C enrichment, kinetic, or steady state measurements of metabolic flux; 13 C isotopomer analysis approaches; 13 C( 2 H) magnetic resonance spectroscopy methodologies; and in vivo 13 C magnetic resonance spectroscopy. Some illustrative applications are described.
ABSTRACT:
We provide an overview of 13 C magnetic resonance spectroscopy methods and their applications as an established metabolic tool with an emphasis on the use of high-resolution 13 C magnetic resonance spectroscopy and 13 C isotopomer analysis. Topics addressed include general properties of the 13 C magnetic resonance spectroscopy spectrum; different 13 C magnetic resonance spectroscopy acquisition protocols; determination of fractional 13 C enrichment, kinetic, or steady state measurements of metabolic flux; 13 C isotopomer analysis approaches; 13 C( 2 H) magnetic resonance spectroscopy methodologies; and in vivo 13 C magnetic resonance spectroscopy. Some illustrative applications are described.
INTRODUCTION
The first 13 C magnetic resonance spectroscopy ( 13 C MRS) study of a living organism was probably reported in 1972 (1) . Authors followed the metabolism of (1-13 C) glucose by a eukaryotic cell system and concluded that the use of this pioneering technique "could have numerous applications for in vivo metabolic studies." Since then, 13 C MRS has developed steadily to a method routinely used in metabolic research with cells, perfused organs, animals, and even humans (2) (3) (4) (5) . This progress has been favored by the ability of 13 C MRS to (i) perform repetitive, noninvasive measurements of metabolic processes as they proceed in their own intracellular environment and (ii) its capacity to measure unique physical properties not detectable by other methodologies, such as spin coupling patterns, isotopic shifts, or magnetic relaxation times T 1 and T 2 . These properties have been shown to provide valuable information on the operation in situ of specific metabolic pathways or the dynamics of some important biological assemblies, exceeding in many cases the interpretations provided by previously used radioactive, spectrophotometric, or fluorimetric approaches. 13 C MRS allows detecting magnetic resonances from 13 C, the only stable isotope of carbon having a magnetic moment. The natural abundance for 13 C is roughly 1.1% of the total carbon and its magnetogyric ratio is approximately one-fourth of that of the proton. These two circumstances make 13 C MRS an insensitive technique (6) . Despite this, natural abundance 13 C resonances from carbons of the fatty acid chains of triglycerides are classically observed in most tissues, and glycogen carbons can be detected in the liver and muscle of fed animals and man (2, 3, 7) . The sensitivity problem can be improved markedly by using 13 C enriched substrates. The combination of 13 C MRS detection and substrates selectively enriched in 13 C in specific positions have made it possible to follow in vivo and in vitro the activity of a large variety of metabolic pathways in cells, animals, and humans. These include glycolysis and the pentose phosphate pathway, glycogen synthesis and degradation, gluconeogenesis, the tricarboxylic acid cycle, ketogenesis, ureogenesis and the glutamate, glutamine, GABA cycle in brain, and others (see references [2] [3] [4] for reviews).
The design of 13 C MRS experiments with selectively 13 C-enriched substrates is similar to the classical radiolabeling experiments using 14 C. A relevant difference is that 13 C precursors are administered in substrate amounts, whereas 14 C substrates are used in tracer amounts. However, 13 C MRS presents important advantages over 14 C. First, the metabolism of the 13 C-labeled substrate can be followed in real time, in situ, and noninvasively (4, 5) . Second, even if tissue extracts are prepared, the detection of 13 C in the different carbon resonances of a specific metabolite does not require separation and carbon by carbon degradation, a prerequisite in the experiments with radioactive 14 C (8). Finally, the analysis by 13 C MRS of homonuclear spin-coupling patterns and isotope effects allows investigation if two or more 13 C atoms occupy contiguous positions in the same metabolite molecule. The latter approach represents, as will be illustrated later in this article, an enormous gain in information as compared with the classical radioactive 14 C experiments (8 ) . As a counterpart to these advantages, 13 C MRS is significantly less sensitive than other conventional metabolic techniques, such as radioactive counting, mass spectrometry, and spectrophotometric or fluorimetric methods.
The purpose of this article is to provide an introduction to 13 C MRS methods and applications with particular reference to high-resolution 13 C NMR and 13 C isotopomer approaches. The methodology described here refers mainly to studies performed with tissue extracts but provides an adequate framework to understand the approaches used with in situ animals and human beings. More information on the latter aspects may be found in references (9 -12) or in NMR in Biomedicine's 2003 special issue titled " 13 C NMR Studies of Cerebral Metabolism." Other reviews cover in more detail the metabolic information derived from 13 C isotopomer analysis in the adult mammalian brain (13) or in primary cultures of neural cells (14, 15) .
METHODOLOGY

The
C MRS Spectrum: Spin Coupling Patterns and Isotopic Shifts
13 C resonances are distributed over a large chemical shift range and experience low relaxation rates (16) . Normally, high-resolution 13 C MRS spectra of metabolites depict a collection of well-resolved narrow resonances distributed over large chemical shift range (ϳ 250 ppm), even in viscous media as those found in vivo. Figure 1 shows typical proton-decoupled 13 C MRS spectra of perchloric acid extracts obtained from the brain of rats infused with (1,2- ] as compared with the natural abundance 13 C MRS spectrum of a rat infused with unlabeled glucose (17) . The most important resonances detected are those from the carbons of glutamate, glutamine, GABA, NAA, inositol, and glucose. The increased intensity of the resonances observed in the upper panels clearly indicates that the 13 C label has been incorporated in cerebral metabolites. Indeed, the difference between the intensity of the natural abundance signal and the total intensity of the corresponding multiplet resonance in the spectrum obtained with 13 C-labeled substrate reveals the net amount of 13 C incorporated in the corresponding carbon. Most of the resonances observed in the upper panel of Fig. 1 depict an apparent triplet structure produced by homonuclear 13 C-13 C coupling. These pseudotriplets are derived from the superposition of doublets originated in those metabolites containing two contiguous 13 C atoms in the same molecule or from singlets, corresponding to those metabolites containing the 13 C atom bonded to 12 C neighbors. Figure 2 and reference (13) illustrate more clearly these aspects. If pathway A incorporates one 13 C atom from the labeled substrate in position i of metabolite M, a singlet resonance will appear at frequency i . If by any chance the 13 C atom from the substrate is incorporated through a different mechanism (pathway B) in position i ϩ 1 of M, a new singlet resonance will appear, now located at a different frequency i ϩ 1 in the 13 C MRS spectrum. It becomes then possible to determine the relative contributions of pathways A and B to the formation of M by the relative intensities of the 13 C resonance at i to that of i ϩ 1 . If pathways A and B are both active, 13 C atoms may be incorporated simultaneously at positions i and i ϩ 1 of the same metabolite molecule. In this case, a new interaction appears between the adjacent magnetic moments of contiguous 13 C nuclei. This interaction splits the original singlet resonances into doublets. This is so because the multiplicity of 13 C resonance coupled to nucleus X is given by the rule 2nI ϩ 1, where n is the number of X nuclei coupled to 13 C, and I is their angular momentum (I ϭ 1/2 for X ϭ 1 H, 31 P, 13 C, 15 N or I ϭ 1 for X ϭ 2 H). This interaction is known as homonuclear scalar coupling and is transmitted through the electrons of the 13 C-13 C-bond. Figure 3 illustrates the most important characteristics of 13 C MRS data acquisition and the resulting 13 C MRS spectra for the hypothetical case of a 13 C carbon bonded only to a vicinal proton. Spin coupling to one or more protons complicates the interpretation of the 13 C spectra and thus it is normally removed using a variety of proton decoupling techniques. All decoupling procedures are based on the same principle, the broadband irradiation of all proton resonances with a high-power amplitude-modulated and monochromatic 1 H frequency. The irradiation saturates the Boltzman energy levels of the proton spectrum, removing the macroscopic magnetization of all protons and making the scalar proton couplings disappear from the 13 C spectrum. There are two main proton decoupling methods: broad band decoupling (BB) and composite pulse decoupling (WALTZ). They differ in the type of modulation of the proton frequencies. Whereas BB uses a continuous irradiation of proton frequencies with a train of rectangular pulses of identical duration and opposite phase (16) , composite pulse decoupling uses blocks of 1 H pulses of different pulse lengths and phases (18) . WALTZ sequences are more efficient than BB, allowing decoupling 13 C spectra using less decoupler power and diminishing also the potential dielectric heating of the sample. In addition to the removal of scalar 1 H couplings, 1 H irradiation can cause an increase in the 13 C signal intensity because of the nuclear overhauser enhancement effect (NOE). The NOE effect is a magnetization transfer process from 1 H to 13 C, which may increase the intensity of a 13 C resonance up to threefold in favorable cases. More information on decoupling sequences and NOE enhancement in 13 C MRS is given in the classical monograph by Breitmeier and Voelter (16 ) . Different decoupling schemes are possible that produce proton-coupled or proton-decoupled 13 C MRS spectra containing (or not containing) NOE enhancement. If the 1 H decoupler is not used in conjunction with 13 C excitation (see Fig. 3 , top panel), a proton-coupled 13 C spectrum is obtained. The multiplet structure of the proton-coupled 13 C resonance depends of the number of protons coupled to the observed carbon and follows the rule, 2nI ϩ 1. For n ϭ 1, a doublet is obtained. If the decoupler is gated only during the acquisition of the 13 C FID (inverse gated decoupling), a proton-decoupled spectrum devoid of NOE is obtained. On the contrary, if the decoupler is gated only during the relaxation delay and not during the acquisition (direct gated decoupling), a proton-coupled NOE-enhanced 13 C spectrum is obtained. Inverse-gated decoupling avoids the effects of NOE, whereas direct-gated decoupling generates 1 H-coupled 13 C spectra with complete NOE enhancement. Decoupling during the complete cycle time generates a proton-decoupled NOE-enhanced 13 C spectrum (19) .
C MRS Acquisition: 1 H Decoupling and NOE Enhancement
A different strategy was proposed in 1985 by Rothman et al. (20) . These authors showed that 13 C-labeled metabolites could be detected in vivo with 1 H sensitivity using a 13 C decoupling sequence in con- 13 C MRS spectra under different 1 H-decoupling conditions. Top: protoncoupled 13 C MRS spectrum; middle: proton-decoupled 13 C MRS spectrum without NOE; bottom: proton-decoupled 13 C MRS spectrum with NOE. The 13 C or 1 H symbols at the left of every sequence indicate RF transmitter or decoupler pulses, respectively. junction with 1 H detection (POCE; proton observed carbon edited). Since then, this approach has been used successfully in vivo and in vitro, and several examples are available in the literature (21, 22) .
C MRS Quantitation
The interpretation of 13 C MRS spectra in terms of flux through metabolic pathways requires the quantitation of the 13 C incorporated in specific carbons. This is normally done by expressing 13 C incorporation as a fractional 13 C enrichment in carbon C i (YC i ). The fractional 13 C enrichment YC i is defined as the amount of 13 C relative to the total carbon ( 13 Cϩ 12 C) present in C i .
The measurement of YC i involves (i) the determination of 13 C concentration by 13 C MRS methods and (ii) the measurement of the total carbon concentration by more conventional techniques (automatic ion exchange chromatography for amino acids, HPLC, enzymatic end point methods for other metabolites, and so on).
Special precautions must be taken in the determination of the concentration of 13 C in C i by 13 C MRS because 13 C signal intensities depend on various factors, in addition to the 13 C concentration. Thus, 13 C resonances from carbons with the same 13 C concentration may have different intensities or areas depending on the particular pulsing condition used, the relaxation behavior of the observed carbon, its NOE effect, and acquisition and repetition times.
The intensity, area, or magnetization M(t) of a 13 C carbon resonance is given by Eq. [2] (23):
where M(t) is the area of the resonance under the pulsing conditions used, M(0) is the area of the resonance under equilibrium magnetization conditions, ⌽ is the flip angle used in the 13 C pulse, is the NOE enhancement factor, t is the total cycle time, T 1 is the longitudinal relaxation time, and a is the acquisition time. M(0) is proportional to the concentration of 13 C. Thus, if the 13 C spectrum is acquired under fully relaxed conditions, a comparison of the area M(0) in the sample with the area of the same resonance in a standard solution of known concentration would give a value for the 13 C concentration in the sample. In practice, this procedure is not recommended because T 1 values of 13 C in extracts vary from approximately 3 s in methyl and methylene resonances to 30 s or more in quaternary carbons like those of carboxylic acids. Thus to recover completely the equilibrium magnetization M(0) in the sample, the slowest carbons would require a total cycle time of approximately 150 s. This is incompatible with reasonable acquisition times. Thus, a compromise is normally adopted and M(0) in the sample and standard solutions can be calculated from M(t) measured under partially saturating conditions (3-6 s total cycle time) and predetermined values of T 1 and ⌽ using the equation described above. To favor quantitation, the influence of the NOE factor is avoided using gated decoupling sequences.
Other 13 C MRS quantitation strategies may be used to determine fractional 13 C enrichments: (i) direct comparison of the areas of the 13 C resonances in the sample spectrum with those of the same resonances in the spectrum of a standard solution of known concentration acquired under identical pulsing conditions; (ii) comparison of the intensities of 13 C resonances in the sample spectrum with the intensity of the natural abundance signals (1.1% YC i ) from an experiment performed using an unlabeled substrate; and (iii) use of 1 H MRS to measure the relative area of the 13 C satellites to the total area of the 1 H resonance (see below). Once the 13 C concentration is known, the fractional 13 C enrichment can be calculated and used in mathematical models of metabolism to determine metabolic flux.
DETERMINATION OF METABOLIC FLUX BY
C MRS
Kinetic and Steady-State Methods
The main goal of 13 C MRS studies is to explore qualitatively or quantitatively metabolic flux through a specific step in a pathway, through a whole pathway, or through a combination of several pathways. To measure metabolic flux by in vivo 13 C MRS, a 13 Cenriched precursor is administered (infused, perifused, and injected) to the biological system. After its administration, 13 C atoms from the substrate substitute progressively, because of metabolism, the 12 C atoms previously present in the system. This substitution may be monitored kinetically in some favorable cases by 13 C MRS techniques (24 -27). Once the kinetics of 13 C enrichment are known it becomes possible to fit the time course of 13 C enrich-ment(s) to a metabolic model containing the fractional 13 C enrichment(s) as the dependent variable(s), time as the independent variable, and the unknown fluxes as the parameters to be fitted. This approach allowed calculating the flux through the tricarboxylic acid cycle and the glutamine cycle in the brain of animals and man (9, 25, 26) . Eventually, an isotopic steady state is achieved after continuous administration of a 13 C-enriched substrate. Under steady-state conditions, the rate of incorporation of 13 C equals the rate of disappearance, and principles of conservation of mass and isotope are fulfilled (Fig. 4) .
These principles state that the total amount of carbon ( 13 C ϩ 12 C) and the amount of 13 C entering a carbon pool are equal to the total amount of carbon ( 13 C ϩ 12 C) and 13 C leaving the pool, respectively. It is possible then to set up a series of simultaneous equations relating the fractional 13 C enrichments determined in every carbon to input output fluxes (see Fig. 4 ). The unknown fluxes can be found, provided the number of equations is equal to the number of unknowns. This is many times the limiting condition as the number of fractional 13 C enrichments determined by 13 C MRS or directly measurable fluxes by other conventional methods is small in comparison with the complexity of metabolic transformations investigated. In these cases, the use of simplified models of metabolism has proven to be useful. Examples of the steady-state approach based of isotopic dilution can be found in the classic work of Chance et al. (27) or studies of neural cell metabolism (28, 29).
The
C Isotopomer Approach
The methods based exclusively on the determination of fractional 13 C enrichment neglect the information provided by spin coupling patterns (see Fig. 2 ), resulting in a significant loss of information. Thus, for a five-carbon metabolite such as glutamate, 13 C enrichment determinations would produce at most five different enrichment values, one for every carbon. These number enrichments would support at most five inputoutput equations as described in Fig. 4 .
The gain in information introduced by the use of spin coupling patterns or isotopic shifts is more easily perceived with the following example. For a molecule such as glutamate containing five carbons, five hydrogens, four oxygens, and one nitrogen atom, the possibilities of isotopic substitution with 13 H labeling; more would be detectable using more sophisticated 2D or 3D multinuclear MRS techniques. Input-output equations for each of these isotopomers can be written and solved, allowing a significantly larger number of fluxes to be determined than with the conventional fractional enrichment method. However, the large number of equations demands the use of computer programs to calculate and fit simulated 13 C spectra to experimental ones. At least two algorithms are available that perform this task, TCASIM (30) and META-SIM (31). The isotopomer approach was initially developed for the estimation of the contribution of anaplerotic fluxes to the tricarboxylic acid cycle of the heart (32) and has been extended to the study of metabolic compartmentation in heart (33-36) and brain (13, 28, (37) (38) (39) (40) (41) 13 C as cerebral substrates (13, 17, 31, (37) (38) (39) (40) (41) . An important basis for the use of this approach is the impressive amount of metabolic information contained in homonuclear spin coupling patterns. Figure 5 provides an adequate frame to discuss these aspects by showing schematically the cerebral metabolism of (1,2-13 C 2 ) glucose or (1,2-13 C 2 ) acetate and their effects on 13 C MRS spectra of brain extracts. (1,2-13 C 2 ) glucose is transported from plasma to brain cells through glucose transporters and degraded directly to an equimolar mixture of (2,3-13 C 2 ) and unlabeled pyruvate through the Embden-Meyerhoff pathway. Cytosolic (2,3-13 C 2 ) pyruvate can be reduced to (2,3-13 C 2 ) lactate, transaminated to (2,3-13 C 2 ) alanine, or transported to the mitochondria for oxidative metabolism (46) . In the mitochondrial matrix, (2,3-13 C 2 ) pyruvate can enter the tricarboxylic acid cycle through pyruvate dehydrogenase as (1,2-13 C 2 ) acetyl-CoA or through pyruvate carboxylase as (2,3-13 C 2 ) oxalacetate. In the first turn, (1,2-13 C 2 ) acetyl-CoA produces (4,5-13 C 2 ) ␣Ϫketoglutarate, while (2,3-13 C 2 ) oxalacetate forms (1,2-13 C 2 ) ␣Ϫke-toglutarate. The exchange between ␣-ketoglutarate and glutamate, through aspartate aminotransferase, has been traditionally assumed to be fast compared with the tricarboxyxlic acid flux, and thus glutamate labeling is thought to reflect accurately the labeling in the ␣-ketoglutarate precursor (22) . Thus (4,5-13 C 2 ) and (1,2-13 C 2 ) glutamate reflect 13 C 2 ) acetyl-CoA only in glial cells, bypassing the pyruvate dehydrogenase and pyruvate carboxylase steps of entry into the tricarboxylic acid cycle. These 13 C labeling patterns are adequately reflected in the high-resolution 13 C MRS spectra of brain extracts by the intensities and multiplicities of the 13 C resonances from the individual carbons of glutamate, glutamine, and GABA. This is illustrated in Fig. 1 , which shows representative 13 C MRS spectra obtained from brain extracts after metabolism of (1,2-13 C 2 ) glucose (A), of (1,2-13 C 2 ) acetate (B), or of unlabeled glucose (bottom). At steady state, glutamate carbons C4 (34.2 ppm) and C5 (182.2 ppm) reflect labeling of acetyl CoA carbons C2 and C1, whereas glutamate carbons C1 (175.5 ppm), C2 (55.5 ppm), and C3 (27.7 ppm) reflect labeling in oxalacetate carbons C4, C3, and C2, respectively. The relative proportions of (2,3-13 C 2 ) pyruvate entering the tricarboxylic acid cycle through pyruvate dehydrogenase or pyruvate carboxylase can be estimated by the relative intensities of the doublet resonances observed in the glutamate C4 and C2 carbons, respectively (47, 48) .
In addition, 13 C MRS spectra of brain extracts provide an excellent tool to study cerebral metabolic compartmentation. This is more easily accomplished through the analysis of the homonuclear spin coupling patterns. Indeed, most of the observed resonances in Fig. 1 display an apparent triplet structure derived from the superposition of doublets and singlets. Doublets arise from contiguously 13 C-labeled isotopomers of glutamate, glutamine, and GABA, whereas singlets are derived from the corresponding isotopomers with 13 C carbons having only 12 C neighbors. The presence of cerebral compartmentation is easily demonstrated through the analysis of the glutamate and glutamine C3 and C4 carbon resonances. When (1,2-13 C 2 ) glucose is the substrate, the different singlet/doublet ratio in the glutamate and glutamine C3 carbons is inconsistent with a single pool of acetyl-CoA and oxalacetate condensing at the citrate synthase step of a unique cerebral tricarboxylic acid cycle. Similarly, when (1,2-13 C 2 ) acetate is the substrate, the singlet/ doublet ratio in glutamine C4 is clearly different from that of its precursor glutamate C4, a result inconsistent with the presence of a unique glutamate pool. This difference led to the description of the cerebral pyruvate recycling system, a pathway transforming (1,2- Hydrogen Turnover as Studied by 13 
C MRS
As described previously, several 13 C MRS techniques have been implemented to study the turnover of indi- vidual metabolite carbons by using precursors selectively enriched in 13 C. Because most metabolite carbons are attached to one or more hydrogen atoms, 13 C MRS could also serve as a valuable tool to analyze hydrogen turnover. This is a much faster process than 13 C turnover and therefore allows studying faster reactions. Our laboratory has proposed a double-labeling strategy to investigate hydrogen turnover. Our approach follows by 13 50 -52) . This is possible because high-resolution 13 C MRS is well suited to detect complex deuteration patterns in 13 C-labeled metabolites.
The presence of one or more deuterons geminally or vicinally bound to the observed 13 C implies the appearance of characteristic 2 H isotopic shifts and 2 H- 13 C couplings (50, 51, 53 13 C multiplets. This kind of approach makes it possible to develop novel procedures to investigate and resolve in time fast metabolic processes, as long as they involve exchange of hydrogens by deuterons. In our laboratory, we have monitored the dynamics of exchange from specific hydrogens of hepatic glutamate and aspartate with deuterons from intracellular heavy water. With this approach it became possible to observe directly ␣-ketoglutarate/glutamate exchange and oxalacetate/ aspartate exchange and subcellular compartmentation, by following in a time-resolved manner the sequence of events involved in the traffic of these metabolites through mitochondria and cytosol (42) . In this work, the determination of relative ( 1 H, 2 H, 13 C) isotopomer populations is conveniently accomplished using a simulation program, which allows the quantitative determination of the relative contributions of the individual ( 1 H, 2 H) 13 C multiplets. Figure 7 shows a representative deconvolution of the C2 carbon resonance of (2-13 C) glutamate. Deconvolution of the C2 carbon resonance revealed contributions from five different ( 1 H, 2 H, 13 C) glutamate isotopomers. Notably, these results reveal intracellular glutamate compartmentation and slow ␣-ketoglutarate/glutamate exchange, a circumstance not considered previously. Figure 8 illustrates the kinetics of deuteration of the H2 and H3 hydrogens from (2-13 C) glutamate during perfusions with (3-13 C) alanine in KrebsRinger bicarbonate (KRB) buffer containing 50% 2 H 2 O. The faster timescale of hydrogen exchange allows resolving in time cytosolic deuteration, as those of (2-13 C, 3-2 H) glutamate, and mitochondrial deuterations, as that of (2-13 C, 3,3Ј-2 H 2 ) glutamate (42).
Figure 6
2 H-13 C multiplets and deuterium-induced isotopic shifts in proton-decoupled 13 C MRS spectra. (A) preprotonated carbon, (B) vicinal deuteration, (C-E) geminal deuteration by one, two, or three deuterons. Simulations were performed with the program WINDAISY using the following parameters:
1 J C-H ϭ 20.06 Hz; geminal isotopic shift, ⌬ 1 ϭ Ϫ22.89 Hz/deuteron; vicinal isotopic shift, ⌬ 2 ϭ Ϫ9.89 Hz/deuteron. Reproduced from (50) with permission of the publisher.
In Vivo
C MRS and Clinical C MRS
The possibility to obtain 13 C MRS spectra of metabolism as it proceeds in its own intracellular environment, in animal models or in human beings, represents one of the most attractive possibilities of the 13 C MRS method. Although 13 C MRS can be performed in natural abundance conditions, studies with administration of exogenous 13 C-enriched precursors are more common. If a 13 C label is delivered adequately to an in vivo system, the incorporation of the 13 C label into some relevant metabolites can be dynamically detected in situ by direct 13 C MRS or inverse ( 1 H) 13 C MRS.
A large number of studies using in vivo 13 C MRS has been performed in the intact rodent or human brain. Surface coils constitute the most widespread localization technique, improving the sensitivity and avoiding external interferences (54, 55) . 13 C MRS 3D localization of a selected volume constituted an important methodological challenge approached by several laboratories during the past decade. Parallel to the development of 3D localization, recent improvements in localized shimming provided an additional contribution to the advance of the technique (56, 57) . Both improvements were fundamental to obtain relevant results, opening the field of in vivo 13 C MRS as one of the most powerful techniques in noninvasive studies of neurological processes. Contributions from this technology include (i) observation of the natural abundance signals from some brain metabolites in vivo (e.g., myo-inositol) (54); (ii) in situ detection of (1-13 C) glycogen in the intact brain (58); and (iii) development of noninvasive studies of cerebral metabolic compartmentation, as 13 C labeling of cerebral glutamate and glutamine can be visualized in vivo (57, 59) .
More recently, 13 C MRS approaches have contributed significantly to our understanding of neuronalglial interactions in brain (26, 41, 60, 61) . A brief (42) with permission of the publisher.
Figure 9
Metabolic coupling between neurons and glia. Glutamatergic neurotransmission releases glutamate from the synaptic vesicles to the synaptic cleft. Synaptic glutamate may be then recaptured by specific astrocyte transporters (together with 3Na ϩ ) to produce glutamine through glutamine synthase. Glial glutamine is released to the extracellular space and taken up by neurons, closing the glutamate-glutamine cycle. ATP required for glutamine synthesis (and Na ϩ extrusion) is produced in the astrocyte by degrading plasma glucose, both oxidatively and nonoxidatively. Thus, glutamatergic neurotransmission is coupled to the intercellular glutamine cycle and astrocytic glucose uptake. GLC: glucose, GLN: glutamine, GLU: glutamate, LAC: lactate, TCAg: glial tricarboxylic acid cycle, TCAn: neuronal tricarboxylic acid cycle. summary is outlined in Fig. 9 . Following activation, neurons release glutamate to the synaptic cleft, which either binds to postsynaptic receptors or is recaptured by surrounding astrocytes in the neuropil. Astrocytic glutamate is transformed into glutamine by the ATPdependent glutamine synthase, glutamine being extruded from the astrocyte and recaptured by the neuron. Together, these processes constitute the glutamate-glutamine cycle that underlies the coupling of neuronal and glial metabolisms. The neuronal and glial tricarboxylic acid cycles and the glutamine cycle and been investigated repeatedly by in vivo and in (70) . c Relative flux values were calculated as described in (31) and from the relative 13 C isotopomer populations in glutamate, glutamine, and GABA measured by high-resolution 13 C NMR in rat brain extracts after infusion of (1,2-13 C 2 ) acetate (38 ). d Absolute flux values were determined from the relative values described in note (c) by measuring the absolute rate of GABA accumulation induced by vigabatrin, a selective inhibitor of GABA transaminase (17 ) .
e Determined in vivo from the kinetics of 13 C enrichment in glutamate and glutamine C4 carbons from rat or human brain during infusion of (1-13 C) glucose, respectively (21, 25 ). f Determined in vivo from the kinetics of 13 C labeling in glutamate and glutamine C4 (55 ) . g Determined in vivo from the kinetics of 13 C enrichment in glutamate and glutamine C4, under different conditions of morphine, ␣-chloralose, and pentobarbital anesthesia (71) .
h Determined in the human brain in vivo during (1-13 C) glucose infusion. Glutamate/glutamine exchange concluded to be stoichiometric 1:1 with CMRglc (72) .
i Determined in the human brain during metabolism of (2-13 C) acetate (73) . j Determined in vivo as the inverse of the rate constant of 13 C labeling in cerebral glutamate C4 during (1-13 C) glucose infusions (74 ) . k Determined in the human brain during (1-13 C) glucose infusion with a different model than that used in (f-i) (9). l Only a fraction of glutamine synthesis considered to be derived from neurotransmitter glutamate. Glutamate/glutamine exchange concluded nonstoichiometric with CMRglc, approaching 0.4 rather than the value of 1 concluded in (f-i) (75 ) .
m Determined in the human brain during (1-13 C) acetate metabolism (76 ) . n Originally proposed as an ␣-ketoglutarate exchange between the large and small compartments (69) . n.a.: not applicable, n.d.: not detectable. Adapted from (13) . Reproduced with permission of the publisher. vitro 13 C NMR in a variety of laboratories (26, 41, 60, 61) . Table 2 summarizes values for the tricarboxylic acid cycle flux, as obtained using different in vivo 13 C NMR approaches compared with earlier radioactive isotope techniques and in vitro 13 C isotopomer approaches. In general, tricarboxylic acid cycle fluxes calculated for the adult rat brain were in the range 1.4 -0.5 mol ⅐ min Ϫ1 ⅐ g Ϫ1 , depending on the mathematical model used for the calculation and the degree of anesthesia. Values found in rodent brain were larger than in humans. Table 2 also shows sizes and turnover rates of the glutamate compartments associated to the "large" and "small" glutamate pools. No direct measurements exist to our knowledge of these pool sizes. The values shown are based on the assumption that the small glutamate pool accounts for approximately 10% of total cerebral glutamate during (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) C) glucose metabolism. Recent evidences indicate that the relative sizes and fractional 13 C enrichments of the large and small glutamate pools could depend on the substrate used (40) .
An area of promising development is the clinical use of 13 C MRS. The high cost of the MRS equipment and 13 C isotopes needed for human studies have restricted the use of human 13 C MRS to a small number of laboratories. Despite this, several brain disorders have been investigated using 13 C MRS, which has already provided new and important clues to clinical diagnosis. The following physiopathological processes have been investigated: (i) in vivo rate of NAA synthesis (62); (ii) elucidation of mitochondrial brain disorders (63); (iii) the glutamate-glutamine cycle and glutamate neurotransmission in certain diseases (64) ; and (iv) study of hepatic encephalopathy and impaired consciousness (65) . Additional reviews describing these topics in more detail can be found in (66 -68) .
CONCLUSION
The results obtained in the past two decades have shown that even with a simple 13 C MRS methodology and using conventional substrates such as (1,2-13 C 2 ) glucose and (1,2-13 C 2 ) acetate, it is possible to determine quantitatively metabolic flux through important metabolic pathways in vivo and in vitro. The use of heteronuclear labeling strategies and the increasing power of the associated mathematical modeling may increase significantly the number of pathways amenable to quantitative analysis by 13 C MRS in the near future. Finally, 13 C MRS will still need to overcome some important challenges. Among these are the study of intracellular ␣-ketoglutarate/glutamate, the study of regional metabolism in different brain areas, the quantitative study of neuronal-glial interactions and their alteration in different pathologies, the development microscopic 13 C MRS approaches to unravel metabolism in a single cell, and the routine application of in vivo 13 
